LAN1B_RUMFL
ID LAN1B_RUMFL Reviewed; 80 AA.
AC P0DQM2;
DT 12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT 12-AUG-2020, sequence version 1.
DT 25-MAY-2022, entry version 4.
DE RecName: Full=Lantibiotic Flvalpha.b {ECO:0000303|PubMed:27028884};
DE Flags: Precursor;
GN Name=FlvA1.B {ECO:0000303|PubMed:27028884};
OS Ruminococcus flavefaciens.
OC Bacteria; Firmicutes; Clostridia; Eubacteriales; Oscillospiraceae;
OC Ruminococcus.
OX NCBI_TaxID=1265;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=FD-1;
RX PubMed=27028884; DOI=10.1016/j.chembiol.2015.11.014;
RA Zhao X., van der Donk W.A.;
RT "Structural characterization and bioactivity analysis of the two-component
RT lantibiotic Flv system from a ruminant bacterium.";
RL Cell Chem. Biol. 23:246-256(2016).
CC -!- FUNCTION: Lanthionine-containing peptide antibiotic (lantibiotic) only
CC active on Gram-positive bacteria in synergy with Flvbeta peptides,
CC which are encoded by the same operon than Flvalpha.a. Shows
CC antibacterial activity in synergy with Flvbeta.b, Flvbeta.c, Flvbeta.e
CC and Flvbeta.g. Does not show antibacterial activity when tested with
CC Flvbeta.a, Flvbeta.d, Flvbeta.f and Flvbeta.h (By similarity). The
CC bactericidal activity of lantibiotics is based on depolarization of
CC energized bacterial cytoplasmic membranes, initiated by the formation
CC of aqueous transmembrane pores (By similarity).
CC {ECO:0000250|UniProtKB:P0DQM1, ECO:0000250|UniProtKB:P86475}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P0DQM1}.
CC -!- PTM: The lanthionine formed by Ser-58 and Cys-68 forms a putative lipid
CC II binding motif. {ECO:0000250|UniProtKB:P0DQM1}.
CC -!- PTM: Maturation of FlvA1 peptides involves the enzymatic conversion of
CC Thr, and Ser into dehydrated AA and the formation of thioether bonds
CC with cysteines. Modifications are processed by the flavecin synthetase
CC FlvM1 (By similarity). This is followed by membrane translocation and
CC cleavage of the modified precursor (By similarity).
CC {ECO:0000250|UniProtKB:H2A7G5, ECO:0000250|UniProtKB:P0DQM1}.
CC -!- PTM: Contains DL-lanthionine and DL-beta-methyllanthionine, when
CC coepressed in E.coli with the flavecin synthetase FlvM1.
CC {ECO:0000250|UniProtKB:P0DQM1}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR AlphaFoldDB; P0DQM2; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR GO; GO:0005102; F:signaling receptor binding; IEA:UniProtKB-KW.
DR GO; GO:0019835; P:cytolysis; IEA:UniProtKB-KW.
DR GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
PE 3: Inferred from homology;
KW Antibiotic; Antimicrobial; Bacteriocin; Lantibiotic; Lipid-binding;
KW Secreted; Thioether bond.
FT PROPEP 1..38
FT /note="Cleaved by FlvT"
FT /evidence="ECO:0000305|PubMed:27028884"
FT /id="PRO_0000450390"
FT PEPTIDE 39..80
FT /note="Lantibiotic Flvalpha.b"
FT /evidence="ECO:0000305|PubMed:27028884"
FT /id="PRO_0000450391"
FT MOD_RES 43
FT /note="2,3-didehydrobutyrine; by FlvM1"
FT /evidence="ECO:0000250|UniProtKB:P0DQM1"
FT MOD_RES 47
FT /note="2,3-didehydrobutyrine; by FlvM1"
FT /evidence="ECO:0000250|UniProtKB:P0DQM1"
FT CROSSLNK 52..55
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM1"
FT /evidence="ECO:0000250|UniProtKB:P0DQM1"
FT CROSSLNK 58..68
FT /note="Lanthionine (Ser-Cys); by FlvM1"
FT /evidence="ECO:0000250|UniProtKB:P0DQM1"
FT CROSSLNK 69..74
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM1"
FT /evidence="ECO:0000250|UniProtKB:P0DQM1"
FT CROSSLNK 71..78
FT /note="Beta-methyllanthionine (Thr-Cys); by FlvM1"
FT /evidence="ECO:0000250|UniProtKB:P0DQM1"
SQ SEQUENCE 80 AA; 8458 MW; C1EB6E3DD80AD9CE CRC64;
MNKNPIYRSE EEAKNIACGN VAAELDENSQ ALDAINGAGW KQTIVCTIAQ GTVGCLVSYG
LGNGGYCCTY TVECSKTCNK